BiomX PHGE
NYSE PHGE
$1.67 +0.12 (+7.74%)
As of: Sep 9, 2026 · 3:59 PM EDT

BiomX (PHGE) Non-Current Assets (2018 - 2026)

BiomX's (PHGE) quarterly Non-Current Assets came in at $25.8 million in Q2 2026, up 20.34% year-over-year from $21.4 million in Q2 2025, and up 12289.42% quarter-over-quarter from $208000.0 in Q1 2026.

Analysis

BiomX (PHGE) Non-Current Assets (2018 - 2026) Analysis & Trends

BiomX has disclosed Non-Current Assets across 9 years of filings, most recently posting $25.8 million for Q2 2026.

  • In Q2 2026, Non-Current Assets rose 20.34% year-over-year to $25.8 million; the TTM figure through Jun 2026 stood at $25.8 million (up 20.34% YoY), while the FY2025 annual figure was $208000.0, down 99.08% from the prior year.
  • Non-Current Assets came in at $25.8 million for Q2 2026 at BiomX, up from $208000.0 in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $33.5 million in Q2 2024 to a low of $208000.0 in Q4 2025.
  • Average Non-Current Assets over 5 years is $14.4 million, with a median of $10.1 million recorded in 2022.
  • Year-over-year, Non-Current Assets surged 315.95% in 2024 and sank 99.08% in 2025.
  • Over 5 years, Non-Current Assets stood at $8.6 million in 2022, then declined by 14.49% to $7.4 million in 2023, then surged by 207.06% to $22.7 million in 2024, then tumbled by 99.08% to $208000.0 in 2025, then jumped by 12289.42% to $25.8 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Assets figures were $25.8 million in Q2 2026, $208000.0 in Q1 2026, and $208000.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 60.68 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 35.42 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 14.88 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 23.28 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 1.96 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 5.15 Bn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 938.60 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 24.78 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 468.65 Mn
10 BiomX 1.55 Mn 7.73 Mn 97,000.00 25.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.77 Mn
Mar 31, 2026 208,000.00
Dec 31, 2025 208,000.00
Sep 30, 2025 17.31 Mn
Jun 30, 2025 21.42 Mn
Mar 31, 2025 22.12 Mn
Dec 31, 2024 22.71 Mn
Sep 30, 2024 31.66 Mn
Jun 30, 2024 33.54 Mn
Dec 31, 2023 7.40 Mn
Sep 30, 2023 7.76 Mn
Jun 30, 2023 8.06 Mn
Mar 31, 2023 8.47 Mn
Dec 31, 2022 8.65 Mn
Sep 30, 2022 9.37 Mn
Jun 30, 2022 10.07 Mn
Mar 31, 2022 10.64 Mn
Dec 31, 2021 11.35 Mn
Sep 30, 2021 12.00 Mn
Jun 30, 2021 11.81 Mn